Anemia prevalence and associated risk factors in a single-center ambulatory HIV clinical cohort

AIDS Reader

Volumn 14, Issue 6, 2004, Pages 305-310+313

  Wills, Todd S ^a   Nadler, Jeffrey P ^a   Somboonwit, Charurut ^a   Vincent, Albert ^a   Leitz, Gerhard ^c   Marino, Kimberly ^c   Naik, Eknath ^b   Powers, Stacy ^b   Khan, Nadeem ^a   Laartz, Brent ^a  

^a Dept of Int Med and Infect Dis ^*

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Ortho Biotech Products LP   (United States)

Author keywords

Anemia; Antiretroviral therapy; Hemoglobin; HIV AIDS

Indexed keywords

HEMOGLOBIN; VIRUS RNA; ZIDOVUDINE;

ADOLESCENT; ADULT; AGED; AGING; ANEMIA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENDER; HEMOGLOBIN DETERMINATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEGRO; PREVALENCE; PUBLIC HEALTH SERVICE; RISK FACTOR; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANEMIA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FLORIDA; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VIRAL LOAD;

EID: 3042642000     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Moore RD. Human immunodeficiency virus infection, anemia, and survival. Clin Infect Dis. 1999;29: 44-49.
2. Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:29-33.
3. Mocroft A, Kirk O, Barton SE, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA Study Group. AIDS. 1999;13:943-950.
4. Lundgren JD, Mocroft A, Gatell JM, et al. A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study [published erratum in J Infect Dis. 2002;186:145]. J Infect Dis. 2002;185:178-187.
5. Lundgren JD, Mocroft A, Gatell JM, et al. A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study [published erratum in J Infect Dis. 2002;186:145]. J Infect Dis. 2002;185:178-187.
6. Sullivan P. Associations of anemia, treatments for anemia, and survival in patients with human immunodeficiency virus infection. J Infect Dis. 2002; 185(suppl 2):S138-S142.
7. Volberding P. Consensus statement: anemia in HIV infection-current trends, treatment options, and practice strategies. Anemia in HIV Working Group. Clin Ther. 2000;22:1004-1020.
8. Volberding P. The impact of anemia on quality of life in human immunodeficiency virus-infected patients. J Infect Dis. 2002;185(suppl 2):S110-S114.
9. Semba RD, Shah N, Klein RS, et al. Highly active antiretroviral therapy associated with improved anemia among HIV-infected women. AIDS Patient Care STDS. 2001;15:473-480.
10. Moore RD, Forney D. Anemia in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;29:54-57.
11. Creagh T, Mildvan D, for the Anemia Prevalence Study Group. Greater prevalence of anemia in women and African Americans with HIV/AIDS in the HAART era: a study of 10,000 patients. Presented at the 40th Annual Meeting of the Infectious Diseases Society of America; October 24-27, 2002; Chicago. Abstract 475.
12. Levine AM, Berhane K, Masri-Lavine L, et al. Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2001;26:28-35.
13. Reisler R, Han C, Burman W, et al. Incidence of grade IV events, AIDS and mortality in a large multicenter cohort receiving HAART. Presented at the 9th Conference on Retroviruses and Opportunistic Infections; February 24-28, 2002; Seattle. Abstract 36.
14. Semba RD, Shah N, Klein RS, et al. Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis. 2002;34:260-266.
15. Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. National Center for Health Statistics. Vital Health Statistics. 1999;10(200). Available at: www. cdc.gov/nchs/data/series/ sr_10/sr10_200.pdf. Accessed April 27, 2004.
16. Moore RD. Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy. Semin Hematol. 2000;37(suppl 6): 18-23.
17. Moyle G. Anaemia in persons with HIV infection: prognostic marker and contributor to morbidity. AIDS Rev. 2002;4:13-20.